Preparation and Long-Term Biodistribution Studies of a Pamam Dendrimer G5–Gd-BnDOTA Conjugate for Lymphatic Imaging

References

• Dutta T , GargM , JainNK . Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro . Eur. J. Pharm. Sci.34 ( 2–3 ), 181 – 189 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Perez-Martinez FC , OcanaAV , Perez-CarrionMD , CenaV . Dendrimers as vectors for genetic material delivery to the nervous system . Curr. Med. Chem.19 ( 29 ), 5101 – 5108 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Posadas I , GuerraFJ , CenaV . Nonviral vectors for the delivery of small interfering RNAs to the CNS . Nanomedicine5 ( 8 ), 1219 – 1236 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Wolinsky JB , GrinstaffMW . Therapeutic and diagnostic applications of dendrimers for cancer treatment . Adv. Drug Deliv. Rev.60 ( 9 ), 1037 – 1055 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• El Kazzouli S , El BrahmiN , MignaniSet al. From metallodrugs to metallodendrimers fornanotherapy in oncology: a concise overview . Curr. Med. Chem.19 ( 29 ), 4995 – 5010 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Lo ST , KumarA , HsiehJT , SunXK . Dendrimer nanoscaffolds for potential theranosticsof prostate cancer with a focus on radiochemistry . Mol. Pharm.10 ( 3 ), 793 – 812 ( 2013 ).
   PubMedGoogle Scholar
• Wiener EC , BrechbielMW , BrothersHet al. Dendrimer-based metal-chelates – a new class ofmagnetic-resonance-imaging contrast agents . Magn. Reson. Med.31 ( 1 ), 1 – 8 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Adam G , NeuerburgJ , SpuntrupEet al. Dynamic contrast-enhanced MR-imaging of the upperabdomen – enhancement properties of gadobutrol, gadolinium-DTPA-polylysine, and gadolinium-DTPA-cascade polymer . Magn. Reson. Med.32 ( 5 ), 622 – 628 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Langereis S , de LussanetQG , van GenderenMHPet al. Evaluation of Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging . NMR Biomed.19 ( 1 ), 133 – 141 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Yordanov AT , KobayashiH , EnglishSJet al. Gadolinium-labeled dendrimers as biometric nanoprobes to detect vascular permeability . J. Mat. Chem.13 ( 7 ), 1523 – 1525 ( 2003 ).
   Google Scholar
• Kobayashi H , SatoN , KawamotoSet al. Comparison of the macromolecular MR contrast agents with ethylenediamine-core versus ammonia-core generation-6 polyamidoamine dendrimer . Bioconjug. Chem.12 ( 1 ), 100 – 107 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Swanson SD , Kukowska-LatalloJF , PatriAKet al. Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement . Int. J. Nanomed.3 ( 2 ), 201 – 210 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Kobayashi H , KawamotoS , SagaTet al. Positive effects of polyethylene glycol conjugation to generation-4 polyamidoamine dendrimers as macromolecular MR contrast agents . Magn. Reson. Med.46 ( 4 ), 781 – 788 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Sena LM , FishmanSJ , JenkinsKJet al. Magnetic resonance lymphangiography with a nano-sized gadolinium-labeled dendrimer in small and large animal models . Nanomedicine5 ( 8 ), 1183 – 1191 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Barge A , CravottoG , GianolioE , FedeliF . How to determine free Gd and free ligand in solution of Gd chelates. A technical note . Contrast Media Mol. Imaging1 ( 5 ), 184 – 188 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Ali MM , WoodsM , CaravanPet al. Synthesis and relaxometric studies of a dendrimer-based pH-responsive MRI contrast agent . Chem. Eur. J.14 ( 24 ), 7250 – 7258 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Nwe K , BernardoM , ReginoCAS , WilliamsM , BrechbielMW . Comparison of MRI properties between derivatized DTPA and DOTA gadolinium-dendrimer conjugates . Bioorg. Med. Chem.18 ( 16 ), 5925 – 5931 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• WaveMetrics . www.wavemetrics.com .
   Google Scholar
• Smedley J , TurkbeyB , BernardoMLet al. Tracking the luminal exposure and lymphatic drainagepathways of intravaginal and intrarectal inocula used in nonhuman primate models of HIV transmission . PLoS ONE9 ( 3 ), ( 2014 ).
   Web of Science ®Google Scholar
• Schlesinger J , KoezleI , BergmannRet al. An Y-86-labeled mirror-image oligonucleotide: influence of Y-DOTA isomers on the biodistribution in rats . Bioconjug. Chem.19 ( 4 ), 928 – 939 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Hoeft S , RothK . Structure and dynamics of lanthanoid tetraazacyclododecanetetraacetate DOTA complexes in solution . Chemische Berichte-Recueil.126 ( 4 ), 869 – 873 ( 1993 ).
   Google Scholar
• Aime S , BargeA , BruceJIet al. NMR, relaxometric, and structural studies of the hydration and exchange dynamics of cationic lanthanide complexes of macrocyclic tetraamide ligands . J. Am. Chem. Soc.121 ( 24 ), 5762 – 5771 ( 1999 ).
   Web of Science ®Google Scholar
• Dunand FA , AimeS , MerbachAE . First O-17 NMR observation of coordinated water on both isomers of [Eu(DOTAM)(H2O)]3+: a direct access to water exchange and its role in the isomerization . J. Am. Chem. Soc.122 ( 7 ), 1506 – 1512 ( 2000 ).
   Web of Science ®Google Scholar
• Woods M , KovacsZ , ZhangSR , SherryAD . Towards the rational design of magnetic resonance imaging contrast agents: isolation of the two coordination isomers of lanthanide DOTA-type complexes . Angew Chem. Int. Ed. Engl.42 ( 47 ), 5889 – 5892 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Aime S , BottaM , ErmondiG . NMR-study of solution structures and dynamics of lanthanide(III) complexes of DOTA . Inorg. Chem.31 ( 21 ), 4291 – 4299 ( 1992 ).
   Web of Science ®Google Scholar
• Jacques V , DesreuxJF . Quantitative 2-dimensional EXSY spectroscopy and dynamic behavior of a paramagnetic lanthanide macrocyclic chelate – YbDOTA (DOTA=1,4,7,10-tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid) . Inorg. Chem.33 ( 18 ), 4048 – 4053 ( 1994 ).
   Web of Science ®Google Scholar
• Woods M , KovacsZ , KiralyRet al. Solution dynamics and stability of lanthanide(III) (S)-2-(p-nitrobenzyl)DOTA complexes . Inorg. Chem.43 ( 9 ), 2845 – 2851 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Aime S , BottaM , FasanoMet al. Conformational and coordination equilibria on DOTA complexes of lanthanide metal ions in aqueous solution studied by H-1-NMR spectroscopy . Inorg. Chem.36 ( 10 ), 2059 – 2068 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Inagaki F , MiyazawaT . NMR analyses of molecular-conformations and conformational equilibria with the lanthanide probe method . Prog. Nucl. Magn. Reson. Spectrosc.14 , 67 – 111 ( 1980 ).
   Web of Science ®Google Scholar
• Laus S , SourA , RuloffR , TothE , MerbachAE . Rotational dynamics account for pH-dependent relaxivities of PAMAM dendrimeric, Gd-based potential MRI contrast agents . Chem. Eur. J.11 ( 10 ), 3064 – 3076 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Wiener EC , KondaS , ShadronA , BrechbielM , GansowO . Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor . Invest. Radiol.32 ( 12 ), 748 – 754 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Nwe K , BryantLH , BrechbielMW . Poly(amidoamine) dendrimer based MRI contrast agents exhibiting enhanced relaxivities derived via metal preligation techniques . Bioconjug. Chem.21 ( 6 ), 1014 – 1017 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Biricova V , LaznickovaA , LaznicekM , PolasekM , HermannP . Radiolabeling of PAMAM dendrimers conjugated to a pyridine-N-oxide DOTA analog with In-111: optimization of reaction conditions and biodistribution . J. Pharm. Biomed. Anal.56 ( 3 ), 505 – 512 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Nwe K , XuH , ReginoCASet al. A new approach in the preparation of dendrimer-based bifunctional diethylenetriaminepentaacetic acid MR contrast agent derivatives . Bioconjug. Chem.20 ( 7 ), 1412 – 1418 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Desreux JF , MercinyE , LoncinMF . Nuclear magnetic-resonance and potentiometric studies of the protonation scheme of 2 tetraaza tetraacetic macrocycles . Inorg. Chem.20 ( 4 ), 987 – 991 ( 1981 ).
   Web of Science ®Google Scholar
• Burai L , FabianI , KiralyR , SzilagyiE , BrucherE . Equilibrium and kinetic studies on the formation of the lanthanide(III) complexes, [Ce(DOTA)](-) and [Yb(DOTA)](-) (H(4)DOTA = 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) . J Chem. Soc Dalton ( 2 ), 243 – 248 ( 1998 ).
   Google Scholar
• Toth E , BrucherE , LazarI , TothI . Kinetics of formation and dissociation of lanthanide(III)–DOTA complexes . Inorg. Chem.33 ( 18 ), 4070 – 4076 ( 1994 ).
   Web of Science ®Google Scholar
• Wu SL , HorrocksWD . Kinetics of complex-formation by macrocyclic polyaza polycarboxylate ligands – detection and characterization of an intermediate in the Eu3+-DOTA system by laser-excited luminescence . Inorg. Chem.34 ( 14 ), 3724 – 3732 ( 1995 ).
   Web of Science ®Google Scholar
• Moreau J , GuillonE , PierrardJCet al. Complexing mechanism of the lanthanide cations Eu3+, Gd3+, and Tb3+ with 1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane (DOTA) – characterization of three successive complexing phases: study of the thermodynamic and structural properties of the complexes by potentiometry, luminescence spectroscopy, and EXAFS . Chem. Eur. J.10 ( 20 ), 5218 – 5232 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Wang XY , JinTZ , ComblinVet al. A kinetic investigation of the lanthanide DOTA chelates – stability and rates of formation and of dissociation of a macrocyclic gadolinium(Iii) polyaza polycarboxylic mri contrast agent . Inorg. Chem.31 ( 6 ), 1095 – 1099 ( 1992 ).
   Web of Science ®Google Scholar
• Caravan P , EllisonJJ , McMurryTJ , LaufferRB . Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications . Chem. Rev.99 ( 9 ), 2293 – 2352 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Mullen DG , DesaiA , van DongenMAet al. Best practices for purification and characterization of PAMAM dendrimer . Macromolecules45 ( 12 ), 5316 – 5320 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Lesniak WG , KariapperMST , NairBMet al. Synthesis and characterization of PAMAM dendrimer-based multifunctional nanodevices for targeting alpha(v)beta(3) integrins . Bioconjug. Chem.18 ( 4 ), 1148 – 1154 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Chen Q , LiKA , WenSHet al. Targeted CT/MR dual mode imaging of tumors using multifunctional dendrimer-entrapped gold nanoparticles . Biomaterials34 ( 21 ), 5200 – 5209 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lim J , TurkbeyB , BernardoMet al. Gadolinium MRI contrast agents based on triazine dendrimers: relaxivity and in vivo pharmacokinetics . Bioconjug. Chem.23 ( 11 ), 2291 – 2299 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kobayashi H , KawamotoS , JoSKet al. Macromolecular MRI contrast agents with small dendrimers: Pharmacokinetic differences between sizes and cores . Bioconjug. Chem.14 ( 2 ), 388 – 394 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Kobayashi H , SatoN , HiragaAet al. 3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties . Magn. Reson. Med.45 ( 3 ), 454 – 460 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Kobayashi H , KawamotoS , SagaTet al. Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core . Magn. Reson. Med.46 ( 4 ), 795 – 802 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Margerum LD , CampionBK , KooMet al. Gadolinium(III) DO3A macrocycles and polyethylene glycol coupled to dendrimers – effect of molecular weight on physical and biological properties of macromolecular magnetic resonance imaging contrast agents . J. Alloys Compd.249 ( 1–2 ), 185 – 190 ( 1997 ).
   Web of Science ®Google Scholar